• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 516438 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1418938190 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1418938190 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Alkermes is Among the Companies in the Biotechnology Industry With the Lowest PEG Ratio (ALKS, UTHR, ANIK)

Published on Wed, 06/12/2013 - 11:15
By Robert Cotter

Below are the three companies in the Biotechnology industry with the lowest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. Generally, the lower the PEG, the better.

Alkermes (NASDAQ:ALKS) is lowest with a PEG ratio of 0.25. Alkermes, Inc. develops products based on drug delivery technologies. The Company is focusing on controlled, sustained release of injectable drugs, as well as the delivery of drugs into the brain past the blood-brain barrier. Alkermes is also focusing on the oral delivery of drugs, and the development of pharmaceutical products based on pulmonary drug delivery technologies.

Alkermes has overhead space with shares priced $30.53, or 1.5% below the average consensus analyst price target of $31.00. Alkermes shares have support at the 50-day moving average (MA) of $29.42 and additional support at the 200-day MA of $22.66.

United Therapeutics (NASDAQ:UTHR) is next with a PEG ratio of 0.46.

Finishing up the bottom three is Anika Therapeutics (NASDAQ:ANIK), with a PEG ratio of 0.74.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Shares of Western Digital Rise Above Pre...

Shares of Western Digital (NYSE:WDC) traded today at $112.21, breaking its 52-week high ...

WellCare Health Plans: The Winning Strea...

Shares of WellCare Health Plans (NYSE:WCG) traded at a new 52-week high today of $79.34 ...

Shares of Vornado Realty Trust Rise Abov...

Shares of Vornado Realty Trust (NYSE:VNO) traded at a new 52-week high today of $115.96 ...

Watch for Continued Losses in Shares of ...

Shares of UQM Technologies (AMEX:UQM) traded at a new 52-week low today of $0.85. Appr ...

Universal Electronics Looks to Continue ...

Shares of Universal Electronics (NASDAQ:UEIC) traded today at $63.71, breaking its 52-w ...

Shares of United Community Financial Ris...

Shares of United Community Financial (NASDAQ:UCFC) traded today at $5.50, breaking its ...

TriQuint Semiconductor Looks to Continue...

TriQuint Semiconductor (NASDAQ:TQNT) traded at a new 52-week high today of $26.84. Thi ...

Shares of Target Have Risen Above Previo...

Target (NYSE:TGT) traded at a new 52-week high today of $74.87. So far today approxima ...